Telang, S., O’Neal, J., Tapolsky, G., Clem, B., Kerr, A., Imbert-Ferndandez, Y., & Chesney, J. (2014). Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib. BioMed Central.
Citação norma ChicagoTelang, Sucheta, Julie O’Neal, Gilles Tapolsky, Brian Clem, Alan Kerr, Yoannis Imbert-Ferndandez, and Jason Chesney. Discovery of a PFKFB3 Inhibitor for Phase I Trial Testing That Synergizes With the B-Raf Inhibitor Vemurafenib. BioMed Central, 2014.
MLA CitationTelang, Sucheta, et al. Discovery of a PFKFB3 Inhibitor for Phase I Trial Testing That Synergizes With the B-Raf Inhibitor Vemurafenib. BioMed Central, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.